Retatrutide 50 mg

Precision, documented.

Retatrutide 50 mg is presented in a laboratory-grade lyophilized format for qualified research applications. Every vial is produced with an emphasis on consistency, careful handling, and a presentation that reflects the standards behind The Peptide Group.

Our philosophy is simple: documentation matters as much as design.

Each batch is paired with supporting laboratory documentation, clearly identified for traceability, and packaged with the same attention to detail that defines every product in our catalog.

From the silver label to the final seal, every element is intentional.

Test Twice. Ship Once.

We’d rather be precise than become another gray area in a gray market.

Manufacturer and supplier information has been redacted from the publicly displayed certificate to protect proprietary sourcing information and prevent unauthorized duplication or reuse. No analytical results, purity data, tested contents, or reported quantities have been altered or removed.

Independent Verificaion: Each peptide ships with separate batch-specific analytical documentation from an independent third-party United States laboratory separate from supplier/manufacturer testing displayed here.